RemeGen Co Ltd

Common Name
RemeGen
Country
China (Mainland)
Sector
Healthcare
Industry
Biotechnology
Employees
2,999
Ticker
688331
Exchange
SHANGHAI STOCK EXCHANGE
Description
RemeGen Co., Ltd. is a biotechnology company focusing on the research, development, and commercialization of novel biologics for the treatment of cancer, autoimmune disorders, and other serious diseas...

RemeGen's Climate Target Data Preview

As of 2023, RemeGen has disclosed 2 climate targets aimed at reducing its greenhouse gas (GHG) emissions. These include 2 absolute reduction targets, signaling the company’s commitment to managing and lowering its carbon footprint over time. The targets span various emissions scopes and time horizons, offering insight into RemeGen ’s climate strategy, ambition level, and alignment with global decarbonization goals.

Target TypeScope of TargetUnitTargetTarget Year
Absolute-based Target
Scope 1 - Total, Scope 2 - Total
Metric Tonnes of CO2 equivalent (mtCO2e)
Copy restricted. Please purchase to unlock this data.
2025
Absolute-based Target
Scope 1 - Total, Scope 2 - Total
Metric Tonnes of CO2 equivalent (mtCO2e)
Copy restricted. Please purchase to unlock this data.
2030

This table provides a simplified preview of selected climate targets data points. To access the complete dataset with full disclosures, detailed breakdowns, and source traceability, create a free account to view purchase options.

Insights into RemeGen's Greenhouse Gas Emissions Pathways

As of 2023, RemeGen has set greenhouse gas (GHG) emissions reduction targets that cover its operational emissions (Scope 1 and 2), but not its value chain emissions (Scope 3). This means its reduction efforts currently focus on direct and purchased energy emissions.

Want Full Access to RemeGen's Climate Targets Dataset?
Sign Up